相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。MUC Glycoproteins: Potential Biomarkers and Molecular Targets for Cancer Therapy
Chameli Ratan et al.
CURRENT CANCER DRUG TARGETS (2021)
Anti-VEGF Mediated Immunomodulatory Role of Phytochemicals: Scientific Exposition for Plausible HCC Treatment
Ayana R. Kumar et al.
CURRENT DRUG TARGETS (2021)
Emerging Trends for Radio-Immunotherapy in Rectal Cancer
Claudia Corro et al.
CANCERS (2021)
Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer
Muhammad Tarek Abdel Ghafar et al.
MOLECULAR BIOLOGY REPORTS (2020)
Rationale of combination of anti-PD-1/PD-L1 antibody therapy and radiotherapy for cancer treatment
Hiro Sato et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Regulation of T Helper Cell Fate by TCR Signal Strength
Nayan D. Bhattacharyya et al.
FRONTIERS IN IMMUNOLOGY (2020)
Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade
Eduardo Bonavita et al.
IMMUNITY (2020)
A Roadmap Toward the Definition of Actionable Tumor-Specific Antigens
Robin Minati et al.
FRONTIERS IN IMMUNOLOGY (2020)
Strategies for Targeting Cancer Immunotherapy Through Modulation of the Tumor Microenvironment
Neha Parayath et al.
REGENERATIVE ENGINEERING AND TRANSLATIONAL MEDICINE (2020)
Mitogen-Activated Protein Kinase Inhibitors and T-Cell-Dependent Immunotherapy in Cancer
Sandeep Kumar et al.
PHARMACEUTICALS (2020)
Correlation Between PD-L2 Expression and Clinical Outcome in Solid Cancer Patients: A Meta-Analysis
Huayu Yang et al.
FRONTIERS IN ONCOLOGY (2019)
Clinical utility of pembrolizumab in the management of advanced solid tumors: an evidence-based review on the emerging new data
Pauline du Rusquec et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Next-Generation Cancer Immunotherapy Targeting Glypican-3
Yasuhiro Shimizu et al.
FRONTIERS IN ONCOLOGY (2019)
Metadherin: A Therapeutic Target in Multiple Cancers
Gourav Dhiman et al.
FRONTIERS IN ONCOLOGY (2019)
Application of PD-1 Blockade in Cancer Immunotherapy
Xiaomo Wu et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
MUC1 in Cancer Immunotherapy - New Hope or Phantom Menace?
M. S. Syrkina et al.
BIOCHEMISTRY-MOSCOW (2019)
Phase I study of local radiation and tremelimumab in patients with inoperable locally recurrent or metastatic breast cancer
Di (Maria) Jiang et al.
Oncotarget (2019)
Heat shock proteins create a signature to predict the clinical outcome in breast cancer
Marta Klimczak et al.
SCIENTIFIC REPORTS (2019)
Radioimmunotherapy for the treatment of head and neck cancer
Sara D. Karam et al.
LANCET ONCOLOGY (2019)
Mutation-Derived Neoantigens for Cancer Immunotherapy
John C. Castle et al.
FRONTIERS IN IMMUNOLOGY (2019)
902OAn adaptive, biomarker directed platform study in metastatic urothelial cancer (BISCAY) with durvalumab in combination with targeted therapies
T Powles et al.
ANNALS OF ONCOLOGY (2019)
Combination Radioimmunotherapy Strategies for Solid Tumors
Javeria Zaheer et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4
Shuang Qin et al.
MOLECULAR CANCER (2019)
Harnessing innate immunity in cancer therapy
Olivier Demaria et al.
NATURE (2019)
Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction
Shixiang Wang et al.
ELIFE (2019)
Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma
Houda Bahig et al.
BMC CANCER (2019)
Cytokines in clinical cancer immunotherapy
Pedro Berraondo et al.
BRITISH JOURNAL OF CANCER (2019)
Durvalumab for the treatment of non-small cell lung cancer
Shuji Murakami
EXPERT REVIEW OF ANTICANCER THERAPY (2019)
Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience
Kamal Chamoun et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Delivery technologies for cancer immunotherapy
Rachel S. Riley et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Developing combination strategies using PD-1 checkpoint inhibitors to treat cancer
Emmett V. Schmidt
SEMINARS IN IMMUNOPATHOLOGY (2019)
Double-slit photoelectron interference in strong-field ionization of the neon dimer
Maksim Kunitski et al.
NATURE COMMUNICATIONS (2019)
Vitamin D Is Required for ILC3 Derived IL-22 and Protection From Citrobacter rodentium Infection
Yang-Ding Lin et al.
FRONTIERS IN IMMUNOLOGY (2019)
Heat Shock Proteins in Cancer Immunotherapy
Jugal Kishore Das et al.
JOURNAL OF ONCOLOGY (2019)
Therapeutic Cancer Vaccine and Combinations With Antiangiogenic Therapies and Immune Checkpoint Blockade
Alice Mougel et al.
FRONTIERS IN IMMUNOLOGY (2019)
Predicting responses to platin chemotherapy agents with biochemically-inspired machine learning
Eliseos J. Mucaki et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2019)
Alternative tumour-specific antigens
Christof C. Smith et al.
NATURE REVIEWS CANCER (2019)
Combining Immune Checkpoint Inhibitors: Established and Emerging Targets and Strategies to Improve Outcomes in Melanoma
Duaa O. Khair et al.
FRONTIERS IN IMMUNOLOGY (2019)
Latest developments in MUC1 immunotherapy
Joyce Taylor-Papadimitriou et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2018)
Cancer immunotherapy-targeted glypican-3 or neoantigens
Yasuhiro Shimizu et al.
CANCER SCIENCE (2018)
Cancer vaccines: translation from mice to human clinical trials
Hoyoung Maeng et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
CAR T-cell Therapy: A New Era in Cancer Immunotherapy
Miliotou N. Androulla et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2018)
Role of immune system in tumor progression and carcinogenesis
Shishir Upadhyay et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2018)
Next generation of immune checkpoint therapy in cancer: new developments and challenges
Julian A. Marin-Acevedo et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Driving T-cell immunotherapy to solid tumors
Ken Garber
NATURE BIOTECHNOLOGY (2018)
Yttrium-90-Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy after Cytoreduction with ESHAP Chemotherapy in Patients with Relapsed Follicular Non-Hodgkin Lymphoma: Final Results of a Phase II Study
Soham D. Puvvada et al.
ONCOLOGY (2018)
Combining Immunotherapy and Radiotherapy for Cancer Treatment Current Challenges and Future Directions
Yifan Wang et al.
FRONTIERS IN PHARMACOLOGY (2018)
Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin's lymphoma
Michael D. Jain et al.
THERAPEUTICS AND CLINICAL RISK MANAGEMENT (2018)
Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
Adriana Albini et al.
FRONTIERS IN IMMUNOLOGY (2018)
Oncogenic viruses and Breast Cancer: Mouse Mammary Tumor virus (MMTV), Bovine Leukemia virus (BLV), Human Papilloma virus (HPV), and epstein-Barr virus (EBV)
James S. Lawson et al.
FRONTIERS IN ONCOLOGY (2018)
Radiation therapy and immunotherapy-a potential combination in cancer treatment
N. Asna et al.
CURRENT ONCOLOGY (2018)
Small Molecules as PD-1/PD-L1 Pathway Modulators for Cancer Immunotherapy
Peifu Jiao et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Monoclonal antibodies in cancer immunotherapy
Ilgin Kimiz-Gebologlu et al.
MOLECULAR BIOLOGY REPORTS (2018)
Preclinical and Clinical Therapeutic Strategies Affecting Tumor-Associated Macrophages in Hepatocellular Carcinoma
H. Degroote et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
Michael M. Boyiadzis et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Immune checkpoint inhibitors: recent progress and potential biomarkers
Pramod Darvin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
The dawn of vaccines for cancer prevention
Olivera J. Finn
NATURE REVIEWS IMMUNOLOGY (2018)
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Zhuting Hu et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Immunogenomic Landscape Contributes to Hyperprogressive Disease after Anti-PD-1 Immunotherapy for Cancer
Donghai Xiong et al.
ISCIENCE (2018)
Systematic review: Tumor-associated antigen autoantibodies and ovarian cancer early detection
Renee Turzanski Fortner et al.
GYNECOLOGIC ONCOLOGY (2017)
Targeting Heat Shock Proteins in Cancer: A Promising Therapeutic Approach
Suman Chatterjee et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Biologic response modifiers: Indications, implications, and insights
Benjamin P. Davis et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)
De-novo and acquired resistance to immune checkpoint targeting
Nicholas L. Syn et al.
LANCET ONCOLOGY (2017)
A review of blinatumomab, a novel immunotherapy
Matthew J. Newman et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2016)
CTLA-4 and PD-1 Pathways Similarities, Differences, and Implications of Their Inhibition
Elizabeth I. Buchbinder et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2016)
Turning tumour cells into antigen presenting cells: The next step to improve cancer immunotherapy?
Marie de Charette et al.
EUROPEAN JOURNAL OF CANCER (2016)
Adapting conventional cancer treatment for immunotherapy
Jian Qiao et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2016)
Metadherin peptides containing CD4+ and CD8+ T cell epitopes as a therapeutic vaccine candidate against cancer
Gourav Dhiman et al.
MICROBIOLOGY AND IMMUNOLOGY (2016)
The Immune System in Cancer Pathogenesis: Potential Therapeutic Approaches
Pankita H. Pandya et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2016)
Vaccines for established cancer: overcoming the challenges posed by immune evasion
Sjoerd H. van der Burg et al.
NATURE REVIEWS CANCER (2016)
Imiquimod - Its role in the treatment of cutaneous malignancies
Aditya Kumar Bubna
INDIAN JOURNAL OF PHARMACOLOGY (2015)
Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: A critical review
Emanual Maverakis et al.
JOURNAL OF AUTOIMMUNITY (2015)
Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway
Pei-Pei Li et al.
MEDICAL ONCOLOGY (2015)
Metadherin Regulation of Vascular Endothelial Growth Factor Expression Is Dependent Upon the PI3K/Akt Pathway in Squamous Cell Carcinoma of the Head and Neck
Gang-cai Zhu et al.
MEDICINE (2015)
Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy
Aifen Lin et al.
MOLECULAR MEDICINE (2015)
RNA-Based Vaccines in Cancer Immunotherapy
Megan A. McNamara et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2015)
The Promise of Preventive Cancer Vaccines
Pier-Luigi Lollini et al.
VACCINES (2015)
TALIMOGENE LAHERPAREPVEC (T-VEC) AS CANCER IMMUNOTHERAPY
F. J. Kohlhapp et al.
DRUGS OF TODAY (2015)
Radioimmunotherapy of human tumours
Steven M. Larson et al.
NATURE REVIEWS CANCER (2015)
Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients
E. C. M. Zeestraten et al.
BRITISH JOURNAL OF CANCER (2014)
Epigenetic regulation of glypican-3 in hepatocellular carcinoma
Thu L. Trinh et al.
CANCER RESEARCH (2014)
Human Viral Oncogenesis: A Cancer Hallmarks Analysis
Enrique A. Mesri et al.
CELL HOST & MICROBE (2014)
PI3K pathway inhibitors: potential prospects as adjuncts to vaccine immunotherapy for glioblastoma
Taemin Oh et al.
IMMUNOTHERAPY (2014)
New drug targets in metastatic melanoma
Blanca Homet et al.
JOURNAL OF PATHOLOGY (2014)
Reducing Lung Cancer Mortality: 2014 Update
David P. Carbone
SEMINARS IN ONCOLOGY (2014)
Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells
Loek J. Eggermont et al.
TRENDS IN BIOTECHNOLOGY (2014)
NOD-like receptors: master regulators of inflammation and cancer
Mansi Saxena et al.
FRONTIERS IN IMMUNOLOGY (2014)
Metadherin in prostate, bladder, and kidney cancer: A systematic review
Zhao Wang et al.
MOLECULAR AND CLINICAL ONCOLOGY (2014)
Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell?
Taku Kambayashi et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Human Interferon Alpha-2b: A Therapeutic Protein for Cancer Treatment
Ratih Asmana Ningrum
SCIENTIFICA (2014)
Human hsp70 and HPV16 oE7 fusion protein vaccine induces an effective antitumor efficacy
Jinbao Zong et al.
ONCOLOGY REPORTS (2013)
MUC1-Specific Cytotoxic T Lymphocytes in Cancer Therapy: Induction and Challenge
David Roulois et al.
BIOMED RESEARCH INTERNATIONAL (2013)
Sweeten PAMPs: role of sugar complexed PAMPs in innate immunity and vaccine biology
Ranjeet Singh Mahla et al.
FRONTIERS IN IMMUNOLOGY (2013)
Mitogen-activated protein kinases in innate immunity
J. Simon C. Arthur et al.
NATURE REVIEWS IMMUNOLOGY (2013)
Programmed Death Ligand 2 in Cancer-Induced Immune Suppression
Esdy N. Rozali et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
c-Myc and Cancer Metabolism
Donald M. Miller et al.
CLINICAL CANCER RESEARCH (2012)
Oncogenic activation of glypican-3 by c-Myc in human hepatocellular carcinoma
Li Li et al.
HEPATOLOGY (2012)
HLA-G expression is associated with metastasis and poor survival in the Balb/c nu/nu murine tumor model with ovarian cancer
Aifen Lin et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Cancer and Radiation Therapy: Current Advances and Future Directions
Rajamanickam Baskar et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2012)
Serum anti-AEG-1 auto-antibody is a potential novel biomarker for malignant tumors
Xi Chen et al.
ONCOLOGY LETTERS (2012)
Sipuleucel-T (Provenge) autologous vaccine approved for treatment of men with asymptomatic or minimally symptomatic castrate-resistant metastatic prostate cancer
Thomas A. Gardner et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2012)
Targeting PD-1/PD-L1 interactions for cancer immunotherapy
Laurence Zitvogel et al.
ONCOIMMUNOLOGY (2012)
Heat shock protein 27 (HSP27): biomarker of disease and therapeutic target
Aparna Vidyasagar et al.
FIBROGENESIS & TISSUE REPAIR (2012)
The role of the PD-1 pathway in autoimmunity and peripheral tolerance
Brian T. Fife et al.
YEAR IN IMMUNOLOGY (2011)
Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17
Sophie Agaugue et al.
BLOOD (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Glypican-3: A new target for cancer immunotherapy
Mitchell Ho et al.
EUROPEAN JOURNAL OF CANCER (2011)
Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come
Ayesha Murshid et al.
EXPERT REVIEW OF VACCINES (2011)
Sunitinib facilitates the activation and recruitment of therapeutic anti-tumor immunity in concert with specific vaccination
Anamika Bose et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Metadherin Mediates Lipopolysaccharide-Induced Migration and Invasion of Breast Cancer Cells
Yuhan Zhao et al.
PLOS ONE (2011)
Cancer Immunotherapy: Sipuleucel-T and Beyond
Aimee E. Hammerstrom et al.
PHARMACOTHERAPY (2011)
Involvement of matrix metalloproteinase-3 in CCL5/CCR5 pathway of chondrosarcomas metastasis
Chih-Hsin Tang et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Targeted inhibition of IL-10-secreting CD25- Treg via p38 MAPK suppression in cancer immunotherapy
Kozo Ohkusu-Tsukada et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
The PD-1 pathway in tolerance and autoimmunity
Loise M. Francisco et al.
IMMUNOLOGICAL REVIEWS (2010)
Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma
A. Lin et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
A Heat Shock Protein 70-Based Vaccine with Enhanced Immunogenicity for Clinical Use
Jianlin Gong et al.
JOURNAL OF IMMUNOLOGY (2010)
Immunological mechanism underlying the immune response to recombinant human protein therapeutics
Melody Sauerborn et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression
Byoung Kwon Yoo et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
T Cell Activation by Heat Shock Protein 70 Vaccine Requires TLR Signaling and Scavenger Receptor Expressed by Endothelial Cells-1
Jianlin Gong et al.
JOURNAL OF IMMUNOLOGY (2009)
Immune Manipulation of Advanced Breast Cancer: An Interpretative Model of the Relationship Between Immune System and Tumor Cell Biology
Andrea Nicolini et al.
MEDICINAL RESEARCH REVIEWS (2009)
Astrocyte elevated gene-1 (AEG-1) functions as an oncogene and regulates angiogenesis
Luni Emdad et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
MUC1 mucin is a negative regulator of Toll-like receptor signaling
Keiko Ueno et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2008)
Heat shock proteins: essential proteins for apoptosis regulation
D. Lanneau et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2008)
The p110 gamma isoform of phosphatidylinositol 3-kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites
Molly S. Thomas et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
Effect of glycosylation on protein folding: A close look at thermodynamic stabilization
Dalit Shental-Bechor et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling
S-G Lee et al.
ONCOGENE (2008)
Immunological aspects of cancer chemotherapy
Laurence Zitvogel et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Pathogen subversion of cell-intrinsic innate immunity
Craig R. Roy et al.
NATURE IMMUNOLOGY (2007)
Intracellular NOD-like receptors in host Defense and disease
Thirumala-Devi Kanneganti et al.
IMMUNITY (2007)
Tremelimumab (CP-675,206), a cytotoxic T lymphocyte-associated antigen 4 blocking monoclonal antibody in clinical development for patients with cancer
Antoni Ribas et al.
ONCOLOGIST (2007)
Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists
Holger Kanzler et al.
NATURE MEDICINE (2007)
Programmed cell death 1 gene (PDCD1) polymorphism and pemphigus foliaceus (fogo selvagem) disease susceptibility
Karin Braun-Prado et al.
GENETICS AND MOLECULAR BIOLOGY (2007)
Regulation of the T cell response
S. Romagnani
CLINICAL AND EXPERIMENTAL ALLERGY (2006)
Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis
Peter S. Creticos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Tumor-associated antigen arrays for the serological diagnosis of cancer
Carlos A. Casiano et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
HSP70 vaccine in combination with gene therapy with plasmid DNA encoding sPD-1 overcomes immune resistance and suppresses the progression of pulmonary metastatic melanoma
H Geng et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Heat shock proteins in cancer: chaperones of tumorigenesis
SK Calderwood et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Pathogen recognition and innate immunity
S Akira et al.
CELL (2006)
Triggering TLR signaling in vaccination
D van Duin et al.
TRENDS IN IMMUNOLOGY (2006)
Tumor antigen-specific T helper cells in cancer immunity and immunotherapy
KL Knutson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer
Y Ohigashi et al.
CLINICAL CANCER RESEARCH (2005)
Structural basis for inhibition of the epidermal growth factor receptor by cetuximab
SQ Li et al.
CANCER CELL (2005)
Hsp70 chaperones: Cellular functions and molecular mechanism
MP Mayer et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2005)
Implication of the MAPK pathways in the maturation of human dendritic cells induced by nickel and TNF-α
F Boislève et al.
TOXICOLOGY (2005)
Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity
LP Chen
NATURE REVIEWS IMMUNOLOGY (2004)
Metadherin, a cell surface protein in breast tumors that mediates lung metastasis
DM Brown et al.
CANCER CELL (2004)
Evaluation of a selectively oncolytic adenovirus for local and systemic treatment of cervical cancer
GJ Bauerschmitz et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation
JM Chemnitz et al.
JOURNAL OF IMMUNOLOGY (2004)
Mucins in cancer: Protection and control of the cell surface
MA Hollingsworth et al.
NATURE REVIEWS CANCER (2004)
Tumor-associated antigen arrays to enhance antibody detection for cancer diagnosis
JY Zhang
CANCER DETECTION AND PREVENTION (2004)
Mucin and Toll-like receptors in host defense against intestinal parasites
DM Moncada et al.
TRENDS IN PARASITOLOGY (2003)
The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer
K Vermeulen et al.
CELL PROLIFERATION (2003)
Strategies to target HER2/neu overexpression for cancer therapy
JS Chen et al.
DRUG RESISTANCE UPDATES (2003)
Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer
T Akashi et al.
PANCREAS (2003)
Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation
V Groh et al.
NATURE (2002)
A functional role of HLA-G expression in human gliomas: An alternative strategy of immune escape
H Wiendl et al.
JOURNAL OF IMMUNOLOGY (2002)
Cancer vaccines and immunotherapy
S Dermime et al.
BRITISH MEDICAL BULLETIN (2002)
HSPPC-96: a personalised cancer vaccine
MM Caudill et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2001)
PD-L2 is a second ligand for PD-I and inhibits T cell activation
Y Latchman et al.
NATURE IMMUNOLOGY (2001)
Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin:: Involvement of Toll-like receptors
S Tsuji et al.
INFECTION AND IMMUNITY (2000)
分享论文
